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Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) 
represents golden standard in dyslipidemia treatment in humans. However, its effects 
in animal models of atherosclerosis are very inconsistent. Thus, the aim of this study 
was to evaluate whether statins has hypolipidemic and inflammatory effects in 
apoE/LDLR deficient mouse model of atherosclerosis. The aim of this rigorous thesis 
was to verify whether atorvastatin posses similar effects in apoE/LDL receptor double 
knockout mice that are common in human medicine.  
Female ApoE/LDL receptor-double-knockout mice at 8 weeks of age were 
randomly divided into 2 groups. The control group of animals (n=8) was fed with the 
atherogenic (western type) diet for another 8 weeks. The same atherogenic diet and 
treatment period was used in other two groups where atorvastatin was added to the 
diet at the dosage of 100 mg/kg per day. Biochemical analysis of blood cholesterol 
fractions, ELISA analysis of monocyte chemoattractant protein-1, vascular cell 
adhesion molecule-1 levels in blood, and stereological analysis of atherosclerotic 
plaque size in aortic sinus was performed. 
The eight week atorvastatin treatment in the dosis of 100mg/kg/day led to 
significant improvement of the lipid profile in the apoE/LDL receptor double knockout 
mouses. This hypolipidemic efficiency was accompanied by significant anti-
inflammatory effects. The plasma levels of MCP-1 and the expression of VCAM-1 in 
atherosclerotc lesionwere reduced. 
In conclusion, this study demonstrates that atorvastatin has hypolipidemic and 
anti-inflammatory affects in apoE/LDLR deficient mice as was described in humans. 
Thus, these mice might represent suitable animal model for the study of statins 
effects in experimental atherogenesis. 
 
